[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Stevaert et al., 2021 - Google Patents

Betulonic acid derivatives interfering with human coronavirus 229E replication via the nsp15 endoribonuclease

Stevaert et al., 2021

View PDF
Document ID
1394867474333911265
Author
Stevaert A
Krasniqi B
Van Loy B
Nguyen T
Thomas J
Vandeput J
Jochmans D
Thiel V
Dijkman R
Dehaen W
Voet A
Naesens L
Publication year
Publication venue
Journal of medicinal chemistry

External Links

Snippet

To develop antiviral therapeutics against human coronavirus (HCoV) infections, suitable coronavirus drug targets and corresponding lead molecules must be urgently identified. Here, we describe the discovery of a class of HCoV inhibitors acting on nsp15, a hexameric …
Continue reading at lirias.kuleuven.be (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Similar Documents

Publication Publication Date Title
Stevaert et al. Betulonic acid derivatives interfering with human coronavirus 229E replication via the nsp15 endoribonuclease
Cannalire et al. Targeting SARS-CoV-2 proteases and polymerase for COVID-19 treatment: state of the art and future opportunities
Chen et al. Identifying SARS-CoV-2 entry inhibitors through drug repurposing screens of SARS-S and MERS-S pseudotyped particles
Huff et al. Discovery and mechanism of SARS-CoV-2 main protease inhibitors
Shan et al. Development of potent and selective inhibitors targeting the papain-like protease of SARS-CoV-2
Li et al. Remdesivir metabolite GS-441524 effectively inhibits SARS-CoV-2 infection in mouse models
Chen et al. Synergistic inhibition of SARS-CoV-2 replication using disulfiram/ebselen and remdesivir
Puhl et al. Repurposing the ebola and marburg virus inhibitors tilorone, quinacrine, and pyronaridine: In vitro activity against SARS-CoV-2 and potential mechanisms
Su et al. Molecular Insights into Small‐Molecule Drug Discovery for SARS‐CoV‐2
Narayana et al. The interferon-induced transmembrane proteins, IFITM1, IFITM2, and IFITM3 inhibit hepatitis C virus entry
Kumar et al. Anti-SARS coronavirus agents: a patent review (2008–present)
Saul et al. Old drugs for a new virus: repurposed approaches for combating COVID-19
Wang et al. Spirostaphylotrichin X from a marine-derived fungus as an anti-influenza agent targeting RNA polymerase PB2
Vincetti et al. Discovery of multitarget antivirals acting on both the Dengue virus NS5-NS3 interaction and the host Src/Fyn kinases
Bandarage et al. Novel 2-substituted 7-azaindole and 7-azaindazole analogues as potential antiviral agents for the treatment of influenza
Xu et al. Systemic in silico screening in drug discovery for coronavirus disease (COVID-19) with an online interactive web server
Da Costa et al. Structure-based drug design of potent pyrazole derivatives against rhinovirus replication
Laurini et al. Computational mutagenesis at the SARS-CoV-2 spike protein/angiotensin-converting enzyme 2 binding interface: comparison with experimental evidence
Zhou et al. Potential therapeutic agents and associated bioassay data for COVID-19 and related human coronavirus infections
Biering et al. Screening a library of FDA-approved and bioactive compounds for antiviral activity against SARS-CoV-2
Chen et al. Structure–activity relationship (SAR) Development and discovery of potent indole-based inhibitors of the Hepatitis C Virus (HCV) NS5B Polymerase
Massari et al. Inhibition of influenza virus polymerase by interfering with its protein–protein interactions
Guedan et al. Investigation of the role of protein kinase D in human rhinovirus replication
Novikov et al. Molecular basis of COVID-19 pathogenesis
Puhl et al. Pyronaridine protects against SARS-CoV-2 infection in mouse